文献速递胃肠外科围术期管理与 ERAS

减重手术与酒精使用相关住院及全因死亡:VA队列研究

Association Between Bariatric Surgery and Alcohol Use-Related Hospitalization and All-Cause Mortality in a Veterans Affairs Cohort.
PubMed 文献 · JAMA Surg · 2023-01-01

该队列研究纳入美国127个退伍军人健康中心2008至2021年BMI≥30、接受Roux-en-Y胃旁路术(RYGB)、袖状胃切除术、胃束带术或转诊至MOVE!体重管理项目的患者。经IPTW并校正时间更新的BMI和酒精使用后,RYGB相比MOVE!和袖状胃切除术与酒精使用障碍相关住院风险升高相关;RYGB相比MOVE!死亡风险降低,但该获益随酒精使用增加而减弱。

要点

  • RYGB术后酒精使用障碍相关住院风险高于MOVE!和袖状胃切除术。
  • 袖状胃切除术与MOVE!的酒精相关住院风险无显著差异。
  • RYGB的死亡获益随酒精使用增加而减弱,需重视术前筛选与酒精相关咨询。

核心结论

  • RYGB相比袖状胃切除术和MOVE!项目与酒精使用障碍相关住院风险升高相关。
  • RYGB相比MOVE!的死亡风险降低,但该关联随酒精使用增加而减弱。

研究设计与样本

  • 多中心回顾性队列研究,纳入美国127个退伍军人健康中心2008年1月1日至2021年12月31日BMI≥30的患者。
  • 暴露为RYGB、袖状胃切除术、胃束带术或转诊至MOVE!体重管理项目。
  • 采用倾向评分和序贯Cox回归,包括未校正、IPTW校正及进一步校正时间更新BMI和AUDIT-C评分的模型。

主要发现

  • 共纳入RYGB 1854例、袖状胃切除术4211例、胃束带术265例、MOVE!转诊1364例。
  • 校正时间更新酒精使用和BMI后,RYGB相比MOVE!的AUD相关住院HR为1.70(95%CI 1.20-2.41,P=.003)。
  • RYGB相比袖状胃切除术的AUD相关住院HR为1.98(95%CI 1.55-2.53,P<.001)。
  • 袖状胃切除术相比MOVE!的AUD相关住院HR为0.76(95%CI 0.56-1.03,P=.08),无显著差异。
  • RYGB相比MOVE!的全因死亡HR为0.63(95%CI 0.49-0.81,P<.001),但该关联随酒精使用增加而减弱。

临床怎么用

  • 对考虑RYGB的患者应进行酒精使用评估和术前咨询,并关注术后酒精使用变化。
  • 在减重术式选择时,需权衡RYGB的死亡获益与酒精相关住院风险。

局限性

  • 原文未明确报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Bariatric surgery procedures, in particular Roux-en-Y gastric bypass (RYGB), have been associated with subsequent alcohol-related complications. However, previous studies lack data to account for changes in body mass index (BMI) or alcohol use over time, which are key potential confounders. OBJECTIVE: To evaluate the association between RYGB, sleeve gastrectomy, or gastric banding on subsequent alcohol use disorder (AUD)-related hospitalization and all-cause mortality as compared with referral to a weight management program alone. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included 127 Veterans Health Administration health centers in the US. Patients who underwent RYGB, sleeve gastrectomy, or gastric banding or who were referred to MOVE!, a weight management program, and had a BMI (calculated as weight in kilograms divided by height in meters squared) of 30 or greater between January 1, 2008, and December 31, 2021, were included in the study. EXPOSURES: RYGB, sleeve gastrectomy, or gastric banding or referral to the MOVE! program. MAIN OUTCOMES AND MEASURES: The primary outcome was time to AUD-related hospitalization from the time of bariatric surgery or MOVE! referral. The secondary outcome was time to all-cause mortality. Separate propensity scores were created for each pairwise comparison (RYGB vs MOVE! program, RYGB vs sleeve gastrectomy, sleeve gastrectomy vs MOVE!). Sequential Cox regression approaches were used for each pairwise comparison to estimate the relative hazard of the primary outcome in unadjusted, inverse probability treatment weighting (IPTW)-adjusted (generated from the pairwise logistic regression models), and IPTW-adjusted approaches with additional adjustment for time-updating BMI and categorical Alcohol Use Disorders Identification Test-Concise scores. RESULTS: A total of 1854 patients received RYGB (median [IQR] age, 53 [45-60] years; 1294 men [69.8%]), 4211 received sleeve gastrectomy (median [IQR] age, 52 [44-59] years; 2817 men [66.9%]), 265 received gastric banding (median [IQR] age, 55 [46-61] years; 199 men [75.1%]), and 1364 were referred to MOVE! (median [IQR] age, 59 [49-66] years; 1175 men [86.1%]). In IPTW Cox regression analyses accounting for time-updating alcohol use and BMI, RYGB was associated with an increased hazard of AUD-related hospitalization vs MOVE! (hazard ratio [HR], 1.70; 95% CI, 1.20-2.41; P = .003) and vs sleeve gastrectomy (HR, 1.98; 95% CI, 1.55-2.53; P < .001). There was no significant difference between sleeve gastrectomy and MOVE! (HR, 0.76; 95% CI, 0.56-1.03; P = .08). While RYGB was associated with a reduced mortality risk vs MOVE! (HR, 0.63; 95% CI, 0.49-0.81; P < .001), this association was mitigated by increasing alcohol use over time. CONCLUSIONS AND RELEVANCE: This cohort study found that RYGB was associated with an increased risk of AUD-related hospitalizations vs both sleeve gastrectomy and the MOVE! program. The mortality benefit associated with RYGB was diminished by increased alcohol use, highlighting the importance of careful patient selection and alcohol-related counseling for patients undergoing this procedure.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Mahmud N, Panchal S, Abu-Gazala S, et al. Association Between Bariatric Surgery and Alcohol Use-Related Hospitalization and All-Cause Mortality in a Veterans Affairs Cohort. JAMA Surg. 2023. PMID: 36515960. doi:10.1001/jamasurg.2022.6410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。